Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Huber Martin H. Jr. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Huber Martin H. Jr. (President, CEO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 9,102 options to buy @ $1.26, valued at $11.5k
08/18/2023 4 Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 136,500 options to buy @ $2.785, valued at $380.2k
07/06/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,477 options to buy @ $3.42, valued at $15.3k
06/12/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
04/05/2023 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 3,375 options to buy @ $4.25, valued at $14.3k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 136,500 options to buy @ $2.69, valued at $367.2k
06/23/2022 4/A Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.28, valued at $45.6k
06/17/2022 4 Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.28, valued at $45.6k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2022 4 Huber Martin H. Jr. (PRESIDENT OF R&D AND CMO) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 65,000 options to buy @ $12.66, valued at $822.9k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 10,185 options to buy @ $6.44, valued at $65.6k
10/25/2021 4 Huber Martin H. Jr. (President of R&D and CMO) has filed a Form 4 on Xilio Therapeutics, Inc.
Txns: Granted 157,058 options to buy @ $16, valued at $2.5M
10/21/2021 3 Huber Martin H. Jr. (President of R&D and CMO) has filed a Form 3 on Xilio Therapeutics, Inc.
09/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2020 4 Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 48,096 options to buy @ $8.57, valued at $412.2k
06/24/2020 3 Huber Martin H. Jr. (Director) has filed a Form 3 on Mersana Therapeutics, Inc.
01/22/2019 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Unknown transaction of 12,206 shares @ $75, valued at $915.5k
Disposed/sold 1,250 restricted stock units @ $0
Disposed/sold 8,750 restricted stock units @ $0
Disposed/sold 4,447 restricted stock units @ $0
Disposed/sold 22,727 restricted stock units @ $0
Disposed/sold 75,000 options to buy @ $55.14, valued at $4.1M
Disposed/sold 35,000 options to buy @ $43.39, valued at $1.5M
Disposed/sold 10,782 options to buy @ $178.95, valued at $1.9M
Disposed/sold 39,942 options to buy @ $55.84, valued at $2.2M
09/25/2018 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Sold 371 shares @ $37.63, valued at $14k
Exercised 1,250 restricted stock units @ $0
03/05/2018 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Sold 1,803 shares @ $54.86, valued at $98.9k
Exercised 4,375 restricted stock units @ $0
Exercised 1,483 restricted stock units @ $0
Granted 22,727 restricted stock units @ $0
Granted 39,942 options to buy @ $55.84, valued at $2.2M
12/05/2017 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Sold 829 shares @ $85.24, valued at $70.7k
Exercised 1,750 restricted stock units @ $0
11/20/2017 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Granted 1,750 restricted stock units @ $0
09/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2017 4 Huber Martin H. Jr. (SVP & Cheif Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Sold 829 shares @ $153.02, valued at $126.9k
Exercised 1,750 restricted stock units @ $0
03/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Granted 1,000 shares @ $0
Sold 327 shares @ $121.29, valued at $39.7k
09/23/2016 4 Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.
Txns: Sold 408 shares @ $108.12, valued at $44.1k
Exercised 1,250 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy